Association between γ-Glutamyl Transpeptidase and SARS-CoV-2 Spike Antibody Titers among BNT162b2 Vaccine Recipients

Background: Increased γ-glutamyl transpeptidase (GGT) levels can deplete plasma glutathione, which in turn impairs immune regulation; however, evidence on GGT levels and post-vaccine immunogenicity is lacking. Objective: To examine the association between GGT and SARS-CoV-2 spike IgG antibodies. Met...

Full description

Bibliographic Details
Main Authors: Zobida Islam, Shohei Yamamoto, Tetsuya Mizoue, Yusuke Oshiro, Natsumi Inamura, Takeshi Nemoto, Maki Konishi, Mitsuru Ozeki, Wataru Sugiura, Norio Ohmagari
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/10/12/2142
_version_ 1827636662688022528
author Zobida Islam
Shohei Yamamoto
Tetsuya Mizoue
Yusuke Oshiro
Natsumi Inamura
Takeshi Nemoto
Maki Konishi
Mitsuru Ozeki
Wataru Sugiura
Norio Ohmagari
author_facet Zobida Islam
Shohei Yamamoto
Tetsuya Mizoue
Yusuke Oshiro
Natsumi Inamura
Takeshi Nemoto
Maki Konishi
Mitsuru Ozeki
Wataru Sugiura
Norio Ohmagari
author_sort Zobida Islam
collection DOAJ
description Background: Increased γ-glutamyl transpeptidase (GGT) levels can deplete plasma glutathione, which in turn impairs immune regulation; however, evidence on GGT levels and post-vaccine immunogenicity is lacking. Objective: To examine the association between GGT and SARS-CoV-2 spike IgG antibodies. Methods: Participants were 1479 medical staff (aged 21 to 75 years) who received a SARS-CoV-2 antibody test after their second vaccine and whose GGT levels were measured before the vaccine rollout. Elevated and highly elevated GGT levels were defined as 51–80 and ≥81 U/L, respectively. Multivariable linear regression was used to calculate the means of SARS-CoV-2 spike IgG. Results: In a basic model, both elevated and highly elevated GGT levels were associated with significantly lower antibody titers. The ratio of mean (95% CI) was 0.83 (0.72–0.97) and 0.69 (0.57–0.84) for elevated and highly elevated GGT levels, respectively. However, these associations were largely attenuated after additional adjustment for potential confounders. An inverse association between GGT levels and antibody titers was found in women [0.70 (0.51–0.97)], normal-weight adults [0.71 (0.51–0.98)], and non-drinkers [0.73 (0.46–1.14)] but not in men, overweight adults, and alcohol drinkers. Conclusions: Circulating GGT concentrations were associated with the humoral immune response after COVID-19 vaccination, but this relationship could be ascribed to confounders such as sex, BMI, and alcohol drinking rather than GGT per se.
first_indexed 2024-03-09T15:45:54Z
format Article
id doaj.art-8dd68f34df90417fa811267e02a2ac71
institution Directory Open Access Journal
issn 2076-393X
language English
last_indexed 2024-03-09T15:45:54Z
publishDate 2022-12-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj.art-8dd68f34df90417fa811267e02a2ac712023-11-24T18:33:30ZengMDPI AGVaccines2076-393X2022-12-011012214210.3390/vaccines10122142Association between γ-Glutamyl Transpeptidase and SARS-CoV-2 Spike Antibody Titers among BNT162b2 Vaccine RecipientsZobida Islam0Shohei Yamamoto1Tetsuya Mizoue2Yusuke Oshiro3Natsumi Inamura4Takeshi Nemoto5Maki Konishi6Mitsuru Ozeki7Wataru Sugiura8Norio Ohmagari9Department of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Toyama 1-21-1, Shinjuku-Ku, Tokyo 162-8655, JapanDepartment of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Toyama 1-21-1, Shinjuku-Ku, Tokyo 162-8655, JapanDepartment of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Toyama 1-21-1, Shinjuku-Ku, Tokyo 162-8655, JapanDepartment of Laboratory Testing, Center Hospital, National Center for Global Health and Medicine, Tokyo 162-8655, JapanDepartment of Laboratory Testing, Center Hospital, National Center for Global Health and Medicine, Tokyo 162-8655, JapanDepartment of Laboratory Testing, Center Hospital, National Center for Global Health and Medicine, Tokyo 162-8655, JapanDepartment of Epidemiology and Prevention, Center for Clinical Sciences, National Center for Global Health and Medicine, Toyama 1-21-1, Shinjuku-Ku, Tokyo 162-8655, JapanDepartment of Laboratory Testing, Center Hospital, National Center for Global Health and Medicine, Tokyo 162-8655, JapanCenter for Clinical Sciences, National Center for Global Health and Medicine, Tokyo 162-8655, JapanCenter Hospital, National Center for Global Health and Medicine, Tokyo 162-8655, JapanBackground: Increased γ-glutamyl transpeptidase (GGT) levels can deplete plasma glutathione, which in turn impairs immune regulation; however, evidence on GGT levels and post-vaccine immunogenicity is lacking. Objective: To examine the association between GGT and SARS-CoV-2 spike IgG antibodies. Methods: Participants were 1479 medical staff (aged 21 to 75 years) who received a SARS-CoV-2 antibody test after their second vaccine and whose GGT levels were measured before the vaccine rollout. Elevated and highly elevated GGT levels were defined as 51–80 and ≥81 U/L, respectively. Multivariable linear regression was used to calculate the means of SARS-CoV-2 spike IgG. Results: In a basic model, both elevated and highly elevated GGT levels were associated with significantly lower antibody titers. The ratio of mean (95% CI) was 0.83 (0.72–0.97) and 0.69 (0.57–0.84) for elevated and highly elevated GGT levels, respectively. However, these associations were largely attenuated after additional adjustment for potential confounders. An inverse association between GGT levels and antibody titers was found in women [0.70 (0.51–0.97)], normal-weight adults [0.71 (0.51–0.98)], and non-drinkers [0.73 (0.46–1.14)] but not in men, overweight adults, and alcohol drinkers. Conclusions: Circulating GGT concentrations were associated with the humoral immune response after COVID-19 vaccination, but this relationship could be ascribed to confounders such as sex, BMI, and alcohol drinking rather than GGT per se.https://www.mdpi.com/2076-393X/10/12/2142γ-glutamyl transpeptidaseCOVID-19SARS-CoV-2vaccineimmunogenicity
spellingShingle Zobida Islam
Shohei Yamamoto
Tetsuya Mizoue
Yusuke Oshiro
Natsumi Inamura
Takeshi Nemoto
Maki Konishi
Mitsuru Ozeki
Wataru Sugiura
Norio Ohmagari
Association between γ-Glutamyl Transpeptidase and SARS-CoV-2 Spike Antibody Titers among BNT162b2 Vaccine Recipients
Vaccines
γ-glutamyl transpeptidase
COVID-19
SARS-CoV-2
vaccine
immunogenicity
title Association between γ-Glutamyl Transpeptidase and SARS-CoV-2 Spike Antibody Titers among BNT162b2 Vaccine Recipients
title_full Association between γ-Glutamyl Transpeptidase and SARS-CoV-2 Spike Antibody Titers among BNT162b2 Vaccine Recipients
title_fullStr Association between γ-Glutamyl Transpeptidase and SARS-CoV-2 Spike Antibody Titers among BNT162b2 Vaccine Recipients
title_full_unstemmed Association between γ-Glutamyl Transpeptidase and SARS-CoV-2 Spike Antibody Titers among BNT162b2 Vaccine Recipients
title_short Association between γ-Glutamyl Transpeptidase and SARS-CoV-2 Spike Antibody Titers among BNT162b2 Vaccine Recipients
title_sort association between γ glutamyl transpeptidase and sars cov 2 spike antibody titers among bnt162b2 vaccine recipients
topic γ-glutamyl transpeptidase
COVID-19
SARS-CoV-2
vaccine
immunogenicity
url https://www.mdpi.com/2076-393X/10/12/2142
work_keys_str_mv AT zobidaislam associationbetweengglutamyltranspeptidaseandsarscov2spikeantibodytitersamongbnt162b2vaccinerecipients
AT shoheiyamamoto associationbetweengglutamyltranspeptidaseandsarscov2spikeantibodytitersamongbnt162b2vaccinerecipients
AT tetsuyamizoue associationbetweengglutamyltranspeptidaseandsarscov2spikeantibodytitersamongbnt162b2vaccinerecipients
AT yusukeoshiro associationbetweengglutamyltranspeptidaseandsarscov2spikeantibodytitersamongbnt162b2vaccinerecipients
AT natsumiinamura associationbetweengglutamyltranspeptidaseandsarscov2spikeantibodytitersamongbnt162b2vaccinerecipients
AT takeshinemoto associationbetweengglutamyltranspeptidaseandsarscov2spikeantibodytitersamongbnt162b2vaccinerecipients
AT makikonishi associationbetweengglutamyltranspeptidaseandsarscov2spikeantibodytitersamongbnt162b2vaccinerecipients
AT mitsuruozeki associationbetweengglutamyltranspeptidaseandsarscov2spikeantibodytitersamongbnt162b2vaccinerecipients
AT watarusugiura associationbetweengglutamyltranspeptidaseandsarscov2spikeantibodytitersamongbnt162b2vaccinerecipients
AT norioohmagari associationbetweengglutamyltranspeptidaseandsarscov2spikeantibodytitersamongbnt162b2vaccinerecipients